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Introduction
Data on cardiovascular disease (CVD) mortality in 
relation to various anthropometric measures of obe-
sity are still inconsistent. In recent years, discussion 
has increased about which measure of overweight 
and obesity is the best indicator to identify those 
individuals who are at high CVD risk [1,2]. The most 
popular measures are height and weight, expressed 
preferably as body mass index (BMI). However, 
recent research shows that BMI cannot make the dis-
tinction between an elevated body weight due to high 
levels of lean compared to fat body mass and an 
excess of body fat is more frequently associated with 
metabolic abnormalities than a high level of lean 
body mass [1]. The measurement of the waist cir-
cumference (WC) is used mostly for defining central 
obesity, but this measurement has been criticized for 
not taking into account differences in body height 
[3]. It has been proven that an individual’s percent-
age of body fat is higher in shorter people compared 
to taller people with an equivalent BMI [4]. Recent 
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studies have found that waist:height ratio (WHtR) 
may be used as marker of body fat centralization, 
which could be an efficient predictor of CVD risk 
[3,5]. Measures of WC, waist:hip ratio (WHR) and 
WHtR, which more accurately describe the distribu-
tion of body fat compared with BMI, have been sug-
gested to be more closely associated with clinical 
outcomes and mortality [2,6].
Some investigators show that the strength of the 
association between anthropometric indexes and car-
diovascular risk is population-dependent [7]. 
Different anthropometric indexes of regional adipos-
ity have been proposed for identifying persons at 
higher risk of death; however, research studies spe-
cifically assessing these indexes in large cohorts are 
insufficient [8]. The aim of this study was to estimate 
the trends in anthropometric indexes from 1992 to 
2008 and to evaluate the risk of CVD mortality in 
relation to anthropometric indexes.
Materials and methods
Study sample
Data from the three surveys are presented in this arti-
cle. The first survey in the framework of the 
Multinational Monitoring of Trends and Determinants 
in Cardiovascular Disease (MONICa) study was per-
formed in 1992–1993. The second survey was con-
ducted in 2001–2002 in accordance with MONICa 
study protocol. The third survey was performed in 
2006–2008 in the framework of the Health, alcohol 
and Psychosocial Factors in eastern europe 
(HaPIee) study [9]. These surveys were carried out 
in kaunas city with a population size of 348,624. all 
three random samples of men and women aged 45–64 
years, stratified by gender and age, were randomly 
selected from the kaunas population register data. 
The response rates were: for the first survey − 58.6%; 
for the second − 62.4%; for the third − 58.1%. Data 
from 5147 subjects who were examined for all anthro-
pometric measurements and analysed CVD risk fac-
tors were approved for statistical analysis. Data of 200 
subjects were excluded from the statistical analysis 
because of incomplete information about the anthro-
pometric measurements and/or analysed covariates.
Ethics statement
all three studies were approved by the Regional 
Biomedical Research ethics Committee at the 
lithuanian university of Health Sciences and the 
HaPIee study (2006–2008) and also by the uClH 
Research ethics Committee alpha at university 
College london, uk. all respondents provided writ-
ten informed consent.
Baseline interview
a baseline interview was carried out in each survey. 
Blood pressure (BP), weight and height measure-
ments and laboratory analyses were conducted fol-
lowing the same methodology and the same or 
comparable questionnaires were used.
Anthropometric and clinical measurements
Weight and height were measured with a calibrated 
medical scale and without shoes or heavy clothes. 
BMI was calculated as the weight in kilograms 
divided by the height in metres squared (kg/m2). 
Normal weight was defined as BMI 18.5–24.99 kg/m², 
overweight as BMI 25.0–29.99 kg/m² and obesity as 
BMI ⩾30.0 kg/m². Insufficient weight was defined as 
BMI <18.5 kg/m².
Waist and hip circumferences were measured 
(without upper clothes) by standard tape with an 
accuracy of 0.5 cm. The diagnostic criteria for ele-
vated WC by the american Heart association, 
National Heart, lung, and Blood Institute Scientific 
Statement recommendations are for men WC ⩾102 
cm and for women ⩾88 cm [10]. The criterion of 
abdominal obesity was defined as WC in centimetres 
divided by the hip circumference in centimetres, thus 
for men WHR >0.9 and for women WHR >0.85 was 
defined as abdominal obesity [10]. WHtR was calcu-
lated as WC divided by height.
BP was measured twice using a mercury sphyg-
momanometer and appropriately sized arm cuffs on 
the right arm. The initial measurement was per-
formed after 5 minutes rest. after 2 minutes, the sec-
ond measurement was made. The korotkoff phase 1 
(beginning of the sound) and the fifth phase of 
korotkoff (disappearance of the sound) was recorded 
as systolic BP (SBP) and diastolic BP (DPB) respec-
tively. The mean of the two readings was used. 
arterial hypertension (aH) was defined as mean 
SBP ⩾140 mmHg and/or mean DBP ⩾90 mmHg or 
respondent reported taking medicine for high BP in 
the last 2 weeks.
In all surveys, CVD was determined according to 
following criteria. Coronary heart disease (CHD) 
was determined by: (1) a documented history of 
myocardial infarction (MI) and/or ischaemic changes 
on an electrocardiogram (eCG) coded by the 
Minnesota codes (MC) 1-1 or 1-2 [11]; (2) angina 
pectoris was defined by G. Rose’s questionnaire 
(without MI and/or MC 1-1 or 1-2; (3) [12]; eCG 
findings by MC 1-3, 4-1, 4-2, 4-3, 5-1, 5-2, 5-3, 6-1, 
6-2, 7-1, 8-3 (without MI and/or MC 1-1, 1-2 and 
without angina pectoris). Stroke was determined 
using the question: ‘Has a doctor ever told you that 
you have had a stroke?’
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Laboratory analyses
Fasting blood samples were taken. Serum samples from 
the first two surveys were analysed in the laboratory of 
the Institute of Cardiology of the lithuanian university 
of Health Sciences and serum samples from the third 
survey in the WHO Regional lipid Reference Centre, 
Institute of Clinical and experimental Medicine, 
Prague (Czech Republic). Serum lipid concentrations 
were measured, using a conventional enzymatic 
method. an elevated triglycerides level was defined as 
⩾1.70 mmol/l [10]. Concentration of glucose in capil-
lary blood was determined by an individual glucometer 
‘Glucotrend’ [13]. a high glucose level was defined as 
fasting glucose level ⩾6.10 mmol/l.
Covariates
The respondent’s age, education, smoking status and 
physical activity were collected using a standard 
questionnaire. education was classified into four 
education levels: primary; incomplete secondary; 
secondary or college; university.
Smoking habits were classified to three groups: 
current smokers; former smokers; never smokers. a 
subject who smoked at least one cigarette per day was 
classified as a current smoker. Physical activity was 
assessed by asking about physically demanding activ-
ities in a typical week in summer and winter seasons, 
active transportation to work and physically demand-
ing activities, such as housework, gardening and 
maintenance of the house, in addition to engagement 
in sports, games or hiking. Subjects who were physi-
cally active less than 10 hours per week were classi-
fied as physically inactive.
Follow-up
The participants were followed up from the beginning 
of each baseline health examination until 31 December 
2013 and mortality data were extracted from the 
regional mortality register. The outcome measure of 
interest was CVD mortality (excluding those with a 
documented history of CVD at entry). CVD mortality 
included CHD, stroke and other vascular causes and 
was defined as 390–458 – codes of 9th ICD and I00–
199 – codes of 10th ICD). There were 141 deaths 
from CVD (excluding those with previous CVD at 
entry) (96 men and 45 women). The mean duration 
and SD of follow-up was 8.98±5.12 years among men 
and 9.49±5.03 years among women.
Statistical analysis
all the analyses were performed separately for men 
and women. Descriptive statistics (prevalence rates, 
means and SD) were calculated for variables in each 
survey. linear-by-linear association test (test for lin-
earity) to assess time trends from 1992 to 2008 was 
performed and p<0.05 was defined as statistically 
significant. all surveys were weight adjusted with age 
to the kaunas population census of 2006. In 2006, 
55% (57.0% of men and 53.5% of women) were 
aged 45–54 years and 45% (43.0% of men and 46.5 
of women) were aged 55–64 years. The weights were 
obtained by dividing the population percentage by 
the surveys percentage. Pearson’s correlation coeffi-
cients between anthropometric indexes and CVD 
risk factors were calculated.
The association between anthropometric indexes 
(BMI, WC, WHR, WHtR) and risk of mortality from 
CVD mortality (excluding those with previous CVD 
at entry) was investigated using Cox’s proportional 
hazards regression analysis. First, the association 
between anthropometry indexes and mortality 
changes between surveys was evaluated using likeli-
hood ratio test and the results were not statistically 
significant (p>0.05). Thus, we calculated the associa-
tion between anthropometric indexes and risk of 
mortality from CVD over all three surveys, putting 
survey year in a Cox’s proportional hazards regres-
sion model as a strata variable. Hazard ratios (HRs) 
represented a change in mortality per 1 unit of the 
anthropometric index and per 1 SD change in 
anthropometric indexes. HR was adjusted by age 
(Model 1) and by age, education, aH, fasting glucose 
and triglyceride levels, smoking and physical activity 
(Model 2). all analyses were carried out using SPSS 
version 13 and STaTa IC version 10.
results
Baseline characteristics according to anthropometric 
indexes of three cohorts aged 45–64 years are pre-
sented in Table I. During the period 1992–2008 gen-
erally negative changes in anthropometric indexes 
profile were observed in men: the mean levels of 
BMI, WC, WHR and WHtR increased significantly 
(p<0.001). The prevalence of normal weight and 
overweight decreased, while the prevalence of obesity 
increased over this period (p<0.05). also during this 
period, the prevalence of high levels of WC and high 
levels of WHR increased. The risk profile of over-
weight and obesity did not change in women, but the 
prevalence of high levels of WHR and the mean levels 
of WC, WHR and WHtR increased.
Correlation coefficients among anthropometric 
measures in a kaunas urban population aged 45–64 
years (Table II) indicate that BMI, WC, WHR and 
WHtR were strongly correlated in men and women, 
suggesting that measures of obesity based on these 
 at University College London on November 20, 2015sjp.sagepub.comDownloaded from 
Luksiene et al.  885
Table II. Pearson’s correlation coefficient among anthropometric 
measures in a kaunas urban population aged 45–64 years (data 
adjusted by age).
Men  
(N=2337)
Women  
(N=2810)
 BMI WC WHR WHtR
BMI – 0.908 0.531 0.915
WC 0.917 – 0.761 0.972
WHR 0.690 0.834 – 0.762
WHtR 0.923 0.957 0.842 –
BMI: body mass index; WC: waist circumference; WHR: waist:hip 
ratio; WHtR: waist:height ratio. all correlation coefficients are sig-
nificant (p<0.01).
parameters will provide comparable information. 
However, WHR showed a weaker correlation with the 
other anthropometric measurements in both groups. 
The anthropometric indexes were significantly asso-
ciated with most CVD risk factors (covariates) in 
men and women groups (see table in supplementary 
material).
Characteristics of respondents according to vital 
status and cause of death are shown in Table III. 
Men and women who died from CVD were older, 
lower educated, more physically inactive and had a 
higher aH rate (only in women) than those alive at 
the end of follow up, although BMI, WC, WHR and 
WHtR did not differ. Meanwhile, in the women 
Table I. Characteristics of subjects aged 45–64 years in three cohorts (data adjusted by age).
Characteristics 1992–1993 2001–2002 2006–2008 P for trend
Men (N=389) (N=420) (N=1528)  
Mean age, years (SD) 52.9 (5.69) 52.9 (5.42) 54.9 (5.69) <0.001
Weight, kg, mean (SD) 82.8 (12.8) 84.5 (14.5) 87.2 (15.9) <0.001
Height, cm, mean (SD) 174.5 (6.41) 174.3 (6.19) 175.1 (6.41) 0.021
BMI, kg/m², mean (SD) 27.2 (3.91) 27.7 (4.23) 28.4 (4.71) <0.001
BMI, kg/m², %, (95% CI)
 <18.5   0 0.2 (–0.2 to 0.6) 0.2 (0–0.4) 0.434
 18.5–24.99 31.7 (27.1–36.3) 26.9 (22.6–31.0) 23.7 (21.7–25.9) 0.001
 25.0–29.9 49.9 (44.9–54.9) 45.5 (40.6–50.2) 44.0 (41.5–46.5) 0.039
 ⩾30.0 18.4 (14.5–22.1) 27.4 (23.1–31.7) 32.1 (29.8–34.4) <0.001
WC, cm, mean (SD) 92.4 (10.1) 93.1 (10.9) 95.1 (12.5) <0.001
WC ⩾102 cm, %, (95% CI) 17.1 (13.4–20.8) 19.5 (15.7–23.3) 26.5 (24.3–28.7) <0.001
WHR, mean (SD) 0.92 (0.06) 0.93 (0.07) 0.94 (0.07) <0.001
WHR >0.9, %, (95% CI) 59.3 (54.4–64.2) 68.4 (64.0–72.8) 72.9 (70.7–75.1) <0.001
WHtR, mean (SD) 0.53 (0.06) 0.53 (0.06) 0.54 (0.07) <0.001
Mortality from CVDa
 Number of events  52  17  27  
 Person years 5,818.7 3,771.1 8,205.2  
 Follow-up years, mean (SD) 18.5 (5.6) 11.3 (2.5) 6.4 (1.1)  
 Mortality/10000 person years 87.8 (63.8–112) 43.7 (22.6–64.7) 26.09 (15.1–37.1)  
Women (N=401) (N=551) (N=1858)  
Mean age, years (SD) 53.3 (5.42) 52.9 (5.39) 55.3 (5.70) <0.001
Weight, kg, mean (SD) 75.3 (13.5) 77.1 (15.9) 76.4 (15.2) 0.421
Height, cm, mean (SD) 161.8 (5.27) 161.2 (6.07) 161.7 (5.92) 0.642
BMI, kg/m², mean (SD) 28.8 (5.15) 29.6 (5.76) 29.3 (5.79) 0.422
BMI, kg/m², %, (95% CI)
 <18.5 0.2 (–0.2 to 0.6) 0.3 (–0.1 to 0.8) 0.2 (0–0.4) 0.816
 18.5–24.99 27.9 (22.8–31.6) 22.2 (18.7–25.7) 24.9 (22.9–26.9) 0.681
 25.0–29.9 35.0 (30.2–39.6) 32.6 (28.7–36.5) 36.5 (34.3–38.7) 0.254
 ⩾30.0 36.9 (31.6–41.0) 44.9 (40.6–49.0) 38.4 (36.2–40.6) 0.808
WC, cm; mean (SD) 86.1 (11.8) 86.7 (12.9) 87.8 (13.7) 0.009
WC ⩾88 cm, %, (95% CI) 43.4 (38.5–48.3) 46.3 (42.1–50.5) 45.6 (43.3–47.9) 0.558
WHR, mean (SD) 0.81 (0.07) 0.82 (0.08) 0.84 (0.07) <0.001
WHR >0.85, %, (95% CI) 25.9 (21.6–30.2) 34.1 (30.1–38.1) 41.5 (39.3–43.7) <0.001
WHtR, mean (SD) 0.53 (0.08) 0.54 (0.08) 0.54 (0.09) 0.011
Mortality from CVDa
 Number of events  32   7   6  
 Follow-up years, mean (SD) 20.3 (3.1) 12.2 (1.1) 6.6 (0.8)  
 Mortality/10000 person years 53.9 (36.2–71.6) 16.5 (5.5–27.5) 5.02 (0.6–9.4)  
CVD: cardiovascular disease; CI: confidence interval; BMI: body mass index; WC: waist circumference; WHR: waist:hip ratio; WHtR: 
waist:height ratio.
aMortality from CVD excluded those with previous CVD at entry.
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group, those who died from CVD had a higher WC, 
WHR and WHtR than those alive at the end of 
follow-up.
We evaluated the risk of CVD mortality in rela-
tion to presence of anthropometric indexes. First, 
we analysed CVD mortality risk per 1 unit increase 
of each the anthropometric index (data adjusted by 
age, education, aH, fasting glucose level, triglycer-
ides level, smoking and physical activity habits). The 
results show that only among men was an increase 
of BMI by 1 kg/m² and WC by 1 cm associated with 
a higher risk of CVD death by 8% (HR=1.08, 95% 
confidence interval (CI) 1.03–1.13, p=0.003) and 
by 3% (HR=1.03, 95% CI 1.01–1.05, p=0.002) 
respectively.
CVD mortality risk per 1 SD increase in anthro-
pometric indexes in a population aged 45–64 years is 
shown in Table IV. after adjustment for age (Model 
1), all four anthropometrics measures (BMI, WC, 
WHR, WHtR) were associated with CVD mortality 
risk in the men and women groups (except for BMI 
and WC in women). after additional adjustment 
(Model 2), the four anthropometric measures were 
associated with CVD mortality risk only in men 
(from 40% to 49%). However, among women after 
additional adjustment (Model 2), all four anthropo-
metric measures were not associated with CVD 
mortality risk.
Discussion
Obesity is a major risk factor for development of 
chronic diseases and an important cause of mortality 
[2,5,8]. The lithuanian population is characterized 
by high morbidity and mortality from CVD and a 
high prevalence of obesity [14,15]. Our study pro-
vides the first population-based information on 
trends of the prevalence of overweight, obesity, 
increased WC and WHR over a 17-year period 
(1992–2008) in lithuania. The findings in our longi-
tudinal study show significant changes. The preva-
lence of obesity in men increased over this 17-year 
period from 18.4% to 32.1% and the prevalence of 
high levels of WHR (>0.9) increased from 59.3% to 
72.9%. In women, the risk profile of obesity did not 
change; however, the prevalence of high levels of 
WHR (>0.85) increased from 25.9% to 41.5%. This 
is comparable to the uSa, where in 1988–1994 to 
1999–2000 in NHaNeS surveys, the prevalence of 
obesity in adults in the uSa increased from 23% to 
31% [16,17]. Currently, the uSa has reportedly the 
highest prevalence of obesity in the adult population 
(31%), which is nearly 10 times higher than Japan 
(3.8% in men and 3.2% in women) [17,18]. The 
data from the Stockholm County 1990-2010 Study 
show that during the period 1990–2010, the preva-
lence of obesity increased from 5.5% to 11.2% in 
Table III. Characteristics of the subjects aged 45–64 years according to vital status and cause of death.
Characteristics Men alive Women alive
CVD deathsa N=1962 CVD deathsa N=2637
 N=96 N=45
Mean age, years (SD) 55.8 (5.90)c 53.9 (5.63) 58.9 (4.22)d 54.3 (5.67)
BMI, kg/m², mean (SD) 28.3 (5.49) 28.1 (4.43) 30.6 (5.40) 29.2 (5.70)
WC, cm; mean (SD) 96.0 (13.4) 94.2 (11.8) 90.8 (12.4)c 87.0 (13.2)
WHR, mean (SD) 0.95 (0.07) 0.94 (0.07) 0.86 (0.08)d 0.83 (0.07)
WHtR, mean (SD) 0.55 (0.08) 0.54 (0.07) 0.57 (0.08)b 0.54 (0.08)
Tg, mean (SD) 1.46 (0.77) 1.56 (1.08) 1.41 (0.90) 1.38 (0.79)
FG, mean (SD) 5.95 (2.52) 5.64 (1.11) 6.39 (3.79) 5.65 (1.14)
aH, % 76.7 69.9 81.6c 59.5
Smokers, %
 Former 26.7 27.0 5.1 7.8
 Current 44.2 37.4 5.1 13.0
education lower than secondary, % 38.4c 25.1 47.4b 28.4
Inactive leisure physical activity, % 43.7b 33.1 52.6d 24.3
CVD: cardiovascular disease; BMI: body mass index; WC: waist circumference; WHR: waist:hip ratio; WHtR: waist:height ratio; SBP: 
systolic blood pressure; DBP: diastolic blood pressure; aH: arterial hypertension (SBP ⩾140 and/or DBP ⩾90 mm Hg or treatment); 
Tg: triglycerides; FG: fasting glucose.
Data adjusted by age and stratified by study survey year.
aCVD deaths excluded those with previous CVD at the entry.
bp<0.05.
cp<0.01.
dp<0.001 compared with alive group.
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men and from 4.6% to 10.3% in women [19]. Our 
data add to this body of evidence, indicating that the 
prevalence of obesity has increased over the past 20 
years. Body composition is currently recognized as 
one of the most important global challenges for pub-
lic health.
The recent gender-specific research analyses how 
diseases differ between men and women, for exam-
ple, risk factors for CVD have a different impact in 
men and women [20]. according to new research 
data, there are some differences between reasons for 
obesity among men and women. In women, BMI is 
associated with increased body shame, dietary 
restraint and depressive symptoms, while in men 
BMI is associated with concerns about shape and 
weight but not dietary restraint [21].
Persistent obesity dysregulates metabolic pro-
cesses, including action of insulin on glucose lipid-
free fatty acid metabolism, and severely affects 
processes controlling blood glucose levels, BP and 
lipids [22]. This leads to the development of meta-
bolic syndrome, which comprises a cluster of condi-
tions including hyperglycaemia, dyslipidaemia and 
aH. Many research studies indicate that BMI, WC, 
WHR and WHtR are significantly correlated with 
CVD risk factors, such as dyslipidaemia, aH, type 2 
diabetes [2,23,24]. The findings in our study show 
that all analysed anthropometric indexes are signifi-
cantly associated with CVD risk factors; for this rea-
son, those covariates were included in a multivariable 
regression analysis.
as well as examining time trends in anthropometric 
indexes, our study evaluated associations between 
anthropometric indexes and risk of CVD mortality. 
The results show that, among men, a 1 unit increase in 
BMI and WC were associated with an increased risk of 
CVD death by 8% and 3% respectively (p=0.003). 
One SD increases in all four anthropometric measures 
in men were associated with increased CVD mortality 
risk. Data from the PaMela study show, that a 1 unit 
increase in baseline BMI and WC were associated 
with an increased risk of CVD death by 12% (for 
baseline BMI) and 5% (for baseline WC), respectively. 
after adjustment for confounders, only the increased 
risk of CVD death associated with higher baseline 
BMI remained significant [25]. Data from european 
DeCODe Study of over 46,000 men and women 
aged 24–99 years (median follow-up of 7.9 years) 
showed that all four anthropometric measures of 
abdominal obesity (BMI, WC, WHtR, WHR) had 
positive associations with CVD mortality [26]. The 
PReDIMeD Study also assessed the associations 
between all four anthropometric measurements (WC, 
WHtR, BMI and height) and mortality (with 4.8 years 
of follow-up), but BMI exhibited weaker associations 
with mortality than WC or WHtR [8].
Furthermore, recent studies have suggested that 
BMI should be refined by measuring additional 
indexes of fat distribution, namely WC, WHR or 
WHtR, to better identify higher-risk subjects [1,27]. 
WC and WHtR are reportedly better anthropometric 
measures of abdominal obesity than BMI and have a 
stronger correlation with intra-abdominal fat content 
and cardiometabolic risk factors [6,26,28]. Some 
studies show that WHtR is a better predictor of risk 
factors for CVD and risk of CVD mortality than WC 
[3,6,29]. The findings in our longitudinal study show 
that all analysed anthropometric indexes significantly 
positively correlated with CVD risk factors for both 
men and women. However, multivariate Cox’s 
regressions demonstrated that significant associa-
tions with CVD mortality risk was found only in 
Table IV. CVD mortality riska per 1 SDb increase in anthropometric indexes in subjects aged 45–64 years (kaunas urban population linked 
mortality file).
anthropometric indexes Men Women
HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
Model 1c Model 2d Model 1c Model 2d
BMI, kg/m² 1.32 (1.08–1.62) 1.40 (1.12–1.75) 1.26 (0.97–1.63) 1.06 (0.79–1.44)
WC, cm 1.41 (1.15–1.73) 1.45 (1.15–1.82) 1.36 (0.99–1.85) 1.08 (0.75–1.53)
WHR 1.54 (1.25–1.89) 1.49 (1.19–1.87) 1.66 (1.18–2.35) 1.32 (0.91–1.92)
WHtR 1.43 (1.18–1.74) 1.46 (1.17–1.82) 1.37 (1.01–1.86) 1.08 (0.75–1.54)
HR: hazard ratio; CI: confidence interval; BMI: body mass index; WC: waist circumference; WHR: waist:hip ratio; WHtR: waist:height 
ratio; CVD: cardiovascular disease.
Note. Some values in Table IV are shown in bold because the HR indicates statistically significant change in CVD risk per 1 SD increase 
of the anthropometric indexes.
aThe risk of mortality from CVD was calculated excluding those responders with previous CVD at entry.
b1 SD for anthropometric indexes in the men group: BMI (4.55 kg/m2 ); WC (12.0 cm); WHR (0.071); WHtR (0.068); 1 SD for anthro-
pometric indexes in the women group: BMI (5.69 kg/m2); WC (13.3 cm); WHR (0.074); WHtR (0.085).
cHR adjusted by age and data stratified by study survey year.
dHR adjusted by age, education, blood pressure, fasting glucose level, triglycerides level, smoking, physical activity habits, and data strati-
fied by study survey year.
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men. In women, the main roles played were aH and 
physical inactivity. Therefore, after additional includ-
ing of aH, physical inactivity and other covariates, 
the CVD risk estimates for anthropometric measures 
among women decreased.
Limitation
It is important to be aware of several limitations of 
our results. First, the present study did not examine 
a national sample, but rather included only a random 
sample of 45–64 year olds of an urban population of 
one city (kaunas is the second largest city in 
lithuania); however, our response rates are compara-
ble with other longitudinal studies. Further study is 
needed to examine these associations in other ages or 
in the rural population. Second, healthy nutritional 
habits are an important determinant of obesity. Diet 
status evaluation in these cohorts was based on a 
food frequency questionnaire, but only a few ques-
tions were comparable across all three surveys. For 
this reason, we did not include a measure of nutrition 
habits in the statistical analyses.
The strength of our study includes its large and 
prospective nature, which makes selection and infor-
mation bias less likely. Numerator-denominator bias 
is minimized through linkage of the survey cohorts 
with the mortality register, rather than relying on 
direct contact with participants or their relatives. a 
common protocol also reduces the likelihood of bias. 
In addition, with a wealth of phenotypic data col-
lected, we have been able to adjust for a range of 
potential confounding variables, including age, edu-
cation, aH, fasting glucose level, triglycerides level, 
smoking and physical activity habits in the analyses 
that are presented.
conclusion
The results of this prospective study suggest that 
over a 17-year period the prevalence of obesity and 
high level of WHR has increased in men. The risk 
profile of obesity did not change in women, but 
the prevalence of high levels of WHR increased. 
a significant increase in the risk for CVD mortality 
was associated with increased BMI, WC, WHR and 
WHtR in men.
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